Acurx Pharmaceuticals, INC. (ACXP) SEC Filings — 2025

Filings

• Acurx Narrows Q3 Loss, But Going Concern Doubts Persist — 10-Q · Nov 12, 2025
• Acurx Files S-1 for Lincoln Park Resale, Eyes $9M More in Funding — S-1 · Oct 20, 2025
• Acurx Pharmaceuticals Files 8-K — 8-K · Sep 22, 2025
• Acurx Pharmaceuticals Files 8-K on Shareholder Vote — 8-K · Sep 19, 2025
• Acurx Pharmaceuticals Burns Cash, Eyes Partnerships Amidst Warrant Dilution — 10-Q · Aug 11, 2025
• Acurx Pharmaceuticals Files Proxy Statement — DEFA14A · Aug 5, 2025
• Acurx Seeks Shareholder Nod for Warrant Issuance, Stock Increase — DEF 14A · Aug 4, 2025
• Acurx Pharmaceuticals Files 8-K with Key Updates — 8-K · Jul 31, 2025
• Acurx Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · Jul 17, 2025
• Acurx Pharma Files S-1 for Public Offering, Eyes Capital Raise — S-1 · Jul 15, 2025
• Acurx Pharmaceuticals Files 8-K with Material Agreements — 8-K · Jun 20, 2025
• Acurx Seeks Reverse Stock Split Approval Amid Listing Concerns — DEF 14A · May 29, 2025
• Acurx Pharmaceuticals Files S-1 Registration — S-1 · May 21, 2025
• Acurx Pharmaceuticals Files 8-K on Financials — 8-K · May 13, 2025
• Acurx Pharmaceuticals Q1 2025: Net Loss Narrows to $17.03M — 10-Q · May 12, 2025
• Acurx Pharmaceuticals Files 8-K on Agreements and Equity Sales — 8-K · May 8, 2025
• Acurx Pharmaceuticals Files S-1 Registration — S-1 · Apr 4, 2025
• Acurx Pharmaceuticals Faces Delisting Notice — 8-K · Mar 28, 2025
• Acurx Pharmaceuticals Files 8-K on Financials — 8-K · Mar 18, 2025
• Acurx Pharmaceuticals Files 2024 10-K, Reports Capital Activities — 10-K · Mar 17, 2025
• Acurx Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · Mar 10, 2025
• Acurx Pharmaceuticals Faces Delisting Concerns — 8-K · Feb 26, 2025
• Acurx Pharmaceuticals Files S-1 — S-1 · Jan 31, 2025
• Acurx Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · Jan 7, 2025